Loading song details...
Robert J Motzer M D Receives Schonfeld Award From Kidney Cancer Association
No description available.
MP3 Download
Video Download
Related Songs
2:32
Dr Robert Motzer Discusses The Safety And Efficacy Of Tivozanib In Kidney Cancer
2:33
Dr Robert Motzer Reviews The TIVO 1 Study Survival Findings
2:16
Dr Robert Motzer Analyzes Overall Survival In The TIVO 1 Study
1:56
Dr Robert Motzer Reviews The Phase III COMPARZ Study
6:19
ASCO GU 2013 TIVO 1 Study Shows Tivozanib An Option For Renal Cell Carcinoma Dr Robert Motzer
5:50
Phase II Trial On Nivolumab In MRCC Dr Robert Motzer At ASCO 2014
2:24
Robert J Motzer MD Discusses The Side Effect Profiles Of Combinations In CLEAR Trial
1:39
Robert J Motzer M D Receives Schonfeld Award From Kidney Cancer Association
3:55
Drugs For Metastatic Kidney Cancer Offer Similar Survival
1:42
Robert J Motzer MD Considers The Issue Of Drug Resistance In Treating Advanced CcRCC
10:40
Dr Robert Motzer Genitourinary Oncol Service Memorial Sloan Kettering Cancer Center New York USA
5:46
TIVO 1 Phase 3 Study In Advanced Kidney Cancer
1:16
Robert J Motzer MD Offers Opinion On Whether Findings From The CLEAR Trial Are Practice Changing
2:25
Dr Motzer On A Phase II Trial Of Nivolumab For MRCC
1:07
Robert J Motzer MD Elaborates On Key Findings From The Phase III CLEAR Trial
1:49
Robert J Motzer MD Speculates On The Future Role Of Combination Therapy In Advanced CcRCC
15:16
Community Clinic Translating Data Into Action Practical Strategies For Optimizing First Line R
1:57
Dr Motzer On Nivolumab Versus Everolimus In Renal Call Carcinoma
1:10
Dr Motzer On First Line Treatment Of Metastatic RCC
1:58